ArticleCancer research2019

Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation.

George M Burslem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.